Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
- PMID: 34071306
- PMCID: PMC8198046
- DOI: 10.3390/ijms22115775
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
Abstract
The complex interaction between glioblastoma and its microenvironment has been recognized for decades. Among various immune profiles, the major population is tumor-associated macrophage, with microglia as its localized homolog. The present definition of such myeloid cells is based on a series of cell markers. These good sentinel cells experience significant changes, facilitating glioblastoma development and protecting it from therapeutic treatments. Huge, complicated mechanisms are involved during the overall processes. A lot of effort has been dedicated to crack the mysterious codes in macrophage/microglia recruiting, activating, reprogramming, and functioning. We have made our path. With more and more key factors identified, a lot of new therapeutic methods could be explored to break the ominous loop, to enhance tumor sensitivity to treatments, and to improve the prognosis of glioblastoma patients. However, it might be a synergistic system rather than a series of clear, stepwise events. There are still significant challenges before the light of truth can shine onto the field. Here, we summarize recent advances in this field, reviewing the path we have been on and where we are now.
Keywords: glioblastoma; glioblastoma-associated macrophages/microglia; macrophage; microglia; tumor microenvironment.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in Glioblastoma.Front Immunol. 2021 Jul 29;12:650105. doi: 10.3389/fimmu.2021.650105. eCollection 2021. Front Immunol. 2021. PMID: 34394072 Free PMC article. Review.
-
Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia/macrophages: From basic insights to therapeutic strategies.Crit Rev Oncol Hematol. 2025 Apr;208:104649. doi: 10.1016/j.critrevonc.2025.104649. Epub 2025 Feb 6. Crit Rev Oncol Hematol. 2025. PMID: 39922398 Review.
-
The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.Int J Mol Sci. 2021 Dec 13;22(24):13382. doi: 10.3390/ijms222413382. Int J Mol Sci. 2021. PMID: 34948178 Free PMC article. Review.
-
Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.Brain. 2017 Jun 1;140(6):1548-1560. doi: 10.1093/brain/aww355. Brain. 2017. PMID: 28334886 Review.
-
The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma.J Neuroimmunol. 2021 Aug 15;357:577633. doi: 10.1016/j.jneuroim.2021.577633. Epub 2021 Jun 15. J Neuroimmunol. 2021. PMID: 34153803 Review.
Cited by
-
Investigational Microbiological Therapy for Glioma.Cancers (Basel). 2022 Dec 2;14(23):5977. doi: 10.3390/cancers14235977. Cancers (Basel). 2022. PMID: 36497459 Free PMC article. Review.
-
Correlation of tumor-associated macrophage infiltration in glioblastoma with magnetic resonance imaging characteristics: a retrospective cross-sectional study.Quant Imaging Med Surg. 2023 Sep 1;13(9):5958-5973. doi: 10.21037/qims-23-126. Epub 2023 Aug 15. Quant Imaging Med Surg. 2023. PMID: 37711787 Free PMC article.
-
Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models.Front Med (Lausanne). 2023 May 9;10:1140352. doi: 10.3389/fmed.2023.1140352. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37228396 Free PMC article.
-
Glycosylation Gene Signatures as Prognostic Biomarkers in Glioblastoma.Ann Clin Transl Neurol. 2025 Jul;12(7):1378-1394. doi: 10.1002/acn3.70068. Epub 2025 May 19. Ann Clin Transl Neurol. 2025. PMID: 40386998 Free PMC article.
-
Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis.Int J Mol Sci. 2024 Dec 29;26(1):192. doi: 10.3390/ijms26010192. Int J Mol Sci. 2024. PMID: 39796053 Free PMC article.
References
-
- Pimenta M.G., Otero Á., Guzman D.A.A., Pascual-Argente D., Martín L.R., Sousa-Casasnovas P., García-Martin A., de Oca J.C.R.M., Villaseñor J.J.M., Carretero L.T., et al. Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome. Brain Pathol. 2021;31:365–380. doi: 10.1111/bpa.12927. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical